Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis

Recent studies have indicated that medical options without splenectomy, such as rituximab (RTX) or thrombopoietin receptor agonists (TPO-RAs), can be effective to treat persistent or chronic primary immune thrombocytopenia (ITP). However, it remains to be determined which of these strategies should...

Full description

Bibliographic Details
Main Authors: Yasuyuki Arai, Hiroyuki Matsui, Tomoyasu Jo, Tadakazu Kondo, Akifumi Takaori-Kondo
Format: Article
Language:English
Published: Taylor & Francis Group 2019-11-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2018.1543864